Terbinafin-Mepha 250, Tabletten
7680571740036
CH-57174
Tabletten
Associated product:
TERBINAFIN Mepha cpr 250 mg 14 pce
1 / 3
google
Article details
- Package size
- 14
- Selling units
- 14
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.88 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 44.80
Specialties list
Yes
Generic
Yes
SL addition date:
01/08/2005
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 57174
- Drug name
- Terbinafin-Mepha, Tabletten
- Galenic form
- TAB
- ATC Code
- D01BA02
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 15/02/2005
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.06.0.
- Domain
- Human medicine
Package details
- Description (FR)
- TERBINAFIN Mepha cpr 250 mg 14 pce
- Description (DE)
- TERBINAFIN Mepha Tabl 250 mg 14 Stk
- Market launch
- 15/02/2005
- Narcotic (BTM)
- No
Original drug
Lamisil, Tabletten
GTIN: 7680513060314
CHF 39.75